Axolotl Biosciences
PrivateLast Round
Grant
Nov 21, 2024
Total Funding Raised
$499,000
Company Overview
Axolotl Biosciences operates in Healthcare & Life Sciences and is based in Victoria, British Columbia. Its latest recorded funding round was a Grant round in November 2024.
Axolotl Biosciences is a biotechnology company that develops and provides bio-inks, 3D tissue models, and consulting services for 3D bioprinting to be used in tissue engineering and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axolotl Biosciences Comparables
Compare Axolotl Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BIO INX | 87% | |
| AdBioInk Biosystem Technology | 83% | |
| Humabiologics, Inc. | 82% |
For institutional investors. Book with your work email.
Axolotl Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 21, 2024 | ||||
| Seed | Jan 31, 2023 | ||||
| Grant | Jan 18, 2023 | ||||
| Grant | Jul 8, 2022 | ||||
| Grant | Sep 1, 2021 | ||||
Grant | Jun 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axolotl Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| AM Ventures | Grant |
| National Research Council of Canada | Grant |
| Innovate BC | Grant |
| Next Generation Manufacturing Canada (NGen) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 283% MoM, reaching 1K.
- Nov 21, 2024
Raised $5K from AM Ventures
For institutional investors. Book with your work email.
Axolotl Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axolotl Biosciences's valuation, stock price, and market status.
Is Axolotl Biosciences a public or private company?
Axolotl Biosciences is a private company.
What is the current stock price of Axolotl Biosciences?
Axolotl Biosciences is a private company, so its shares have no public market price. Caplight tracks Axolotl Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axolotl Biosciences worth (valuation)?
Valuation information for Axolotl Biosciences is not publicly available.
Can I buy Axolotl Biosciences stock?
Axolotl Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axolotl Biosciences's last funding round?
Axolotl Biosciences's most recent funding round was Grant on November 21, 2024.
Who are the main investors in Axolotl Biosciences?
Key investors in Axolotl Biosciences include National Research Council Canada Industrial Research Assistance Program, AM Ventures, National Research Council of Canada, Innovate BC, Next Generation Manufacturing Canada (NGen).
Will Axolotl Biosciences IPO soon?
No public IPO plans have been announced for Axolotl Biosciences.
How can I track Axolotl Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Axolotl Biosciences's shares on secondary markets.